The Patent Finder

Aptose Biosciences Inc.

Also on record
Records under this name other than the patents Aptose Biosciences Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.

Back to Aptose Biosciences Inc.

PatentTitleStatus Expires Confidence
US 11,279,703Fused pyrimidine compounds as BRD4 and JAK2 dual inhibitors and methods for use thereof
Lapsed on the fee record
Ended Mar 22, 2026 · From the USPTO record
Lapsed on the fee recordEnded Mar 22, 2026From the USPTO record
US 11,149,047Aryl imidazoles for treatment of cancer
Lapsed on the fee record
Ended Oct 19, 2025 · From the USPTO record
Lapsed on the fee recordEnded Oct 19, 2025From the USPTO record
US 11,104,957Compositions and methods for treating cancers
Lapsed on the fee record
Ended Aug 31, 2025 · From the USPTO record
Lapsed on the fee recordEnded Aug 31, 2025From the USPTO record
US 10,080,739Aryl Imidazoles and Their Use as Anti-Cancer Agents
Term ended
Term ended Aug 9, 2025 · High confidence
Term endedTerm ended Aug 9, 2025High confidence
US 9,567,643Compositions and methods for treating cancers
Lapsed on the fee record
Ended Feb 14, 2025 · From the USPTO record
Lapsed on the fee recordEnded Feb 14, 2025From the USPTO record
US 8,148,3922-indolyl imidazo [4,5-d] phenanthroline derivatives and their use in the treatment of cancer
Lapsed on the fee record
Ended Apr 3, 2024 · From the USPTO record
Lapsed on the fee recordEnded Apr 3, 2024From the USPTO record
US 8,394,8152,4,5-trisubstituted imidazoles and their use as anti-microbial agents
Term ended
Ended no later than Aug 19, 2023 · From the USPTO record
Term endedEnded no later than Aug 19, 2023From the USPTO record
US 8,987,3052,4,5-trisubstituted imidazoles and their use as anti-microbial agents
Lapsed on the fee record
Ended Mar 24, 2023 · From the USPTO record
Lapsed on the fee recordEnded Mar 24, 2023From the USPTO record
US 8,969,372Aryl imidazoles and their use as anti-cancer agents
Lapsed on the fee record
Ended Mar 3, 2023 · Medium confidence
Lapsed on the fee recordEnded Mar 3, 2023Medium confidence
US 7,884,1202,4,5-trisubstituted imidazoles and their use as anti-microbial agents
Lapsed on the fee record
Ended Feb 8, 2023 · From the USPTO record
Lapsed on the fee recordEnded Feb 8, 2023From the USPTO record
10 of 15 patents shown.
Pro members see all 15.
Pro members: see all 15 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited